Cerus
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
1220 Concord Ave Ste 600, Concord, Calif...Phone Number
(925) 288-6000Website
www.cerus.comRevenue
$216.6 MillionStock Symbol
CERSIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About Cerus
Headquartered in Concord, California, Cerus develops and commercializes the INTERCEPT Blood System, a pathogenreduction technology used by blood centers and hospitals to inactivate viruses, bacteria, and parasites in blood components (e.g., platelets and plasma), with additional programs in red blood cells.Explore more
Cerus Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cerus your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Cerus, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Cerus has recently received funding, and reach out quickly before it becomes old news!
Click to see if Cerus had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Cerus
Earning: See what the market has to say on Cerus recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Cerus has new funding data
Product Launch: Get notified when Cerus launches new products
Check out if Cerus is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Cerus
Find more new buyers
Compare Similar Companies to Cerus
Compare insights from companies similar to Cerus, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cerus is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cerus is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cerus.
Cerus financials insights
Gather financial insights about Cerus, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
1997
Stock Offering
$21.3M
2010
Debt
$10M
2014
Debt
$30M
2017
Debt
$40M
2019
Debt
$90M
2020
Stock Offering
$63.3M
Unspecified
$14M
2026
Debt
$110M
Cerus Tech Stack
A closer look at the technologies used by Cerus
See more technologies
Most Recent Scoops
Hiring Plans
Cerus has more open roles in C-Suite than it has had at any time in the past 12 months. Areas of expertise include: Project Management, and Cross-Functional Coordination.
Hiring Plans
Hiring Plans
Cerus has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Person-Based
Person-Based
Project
Laboratory Operations, Medical Research, Clinical Operations
Cerus News & Media
Cerus Corporation (CERS) Gets Upgraded to Buy Post Q1 by BTIG
Cerus Corporation (NASDAQ:CERS) is one of the best oversold growth stocks to invest in now. BTIG upgraded Cerus Corporation (NASDAQ:CERS) to Buy from Neutral on May 1, reiterating a $4 price target. The rating update came after the company announced its financial results for fiscal Q1 2026, with total revenue for the quarter reaching $59.9 million, […]Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer
CONCORD, Calif.--(BUSINESS WIRE)--Mar 16, 2026--Cerus Corporation Chief Financial Officer Kevin Green Divests Significant Stake in Company Stock
Cerus Corporation CFO Kevin Green sells over $169,000 in company stock, sparking discussions among investors regarding the firm's future financial outlook.Cerus Details INTERCEPT Growth Plan, BCA Deal Upside and 2026 RBC Milestones at TD Cowen Conference
Cerus (NASDAQ:CERS) executives used a presentation and fireside chat at the TD Cowen Healthcare Conference to reiterate the company’s focus on making its INTERCEPT Blood System a global standard of care for transfusion medicine, while outlining commercial priorities across U.S. platelets, internatio
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cerus
Sign Up For FreeTo access detailed company insights
Headquartered in Concord, California, Cerus develops and commercializes the INTERCEPT Blood System, a pathogenreduction technology used by blood centers and hospitals to inactivate viruses, bacteria, and parasites in blood components (e.g., platelets and plasma), with additional programs in red blood cells.... Read More
